Pierre is a serial entrepreneur with more than 30 years’ experience in the biopharmaceutical industry. He co-founded Enterome and has led the company since its inception in 2012. Prior to Enterome, Pierre held various C-level positions from commercial operations to business development and M&A at Sanofi ophthalmology, Ethypharm and UroGene (the latter was acquired by Pierre Fabre in 2004). Pierre also founded Fovea Pharmaceuticals, a company acquired by Sanofi in 2009. Pierre also serves as director on the Board of Iltoo Pharma.

Pierre holds a PharmD from Grenoble Faculty of Medicine and Pharmacy, a PhD from University Pierre and Marie Curie and an MBA from INSEAD.